Janne Backman takes over as chair of IRLAB

IRLAB Therapeutics has appointed a new board chair. Janne Backman succeeds Carola Lemne, who is stepping down after eight years on the research company’s board.

Saline recalled after potentially dangerous mix-up

A batch of potentially mislabelled IV infusion bags is being recalled in the US by Otsuka ICU Medical. The company is warning that accidental injection of the p...

Swedish biotech signs blockbuster deal with Novo – ”It’s Nanexa 2.0”

Nanexa has signed a global licensing deal with Danish pharmaceutical giant Novo in an agreement that could be worth up to SEK 13 billion.

From diagnosis to treatment, ZEISS introduces innovations across ZEISS Retina Workflow

ZEISS Medical Technology advances its ZEISS Retina Workflow with digital and surgical enhancements, and new imaging technologies.

Lundbeck relocates US headquarters and establishes innovation hub in Boston

Danish pharmaceutical company Lundbeck is relocating its US headquarters from Deerfield, Illinois, to the Boston region, where the company is also establishing ...

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Stockholm

Multicancer blood test moves closer to FDA approval

A blood test designed to detect signals from more than 50 types of cancer before symptoms appear could be on its way to FDA approval, after an advisory panel of...

Elfcare to integrate health data with ChatGPT – leaves sharing to users

Healthcare company Elfcare has launched a new connector that allows users to share results from its health assessments with AI assistants. Speaking to Life Scie...

Danish BioInnovation Institute sets sights on Europe

Great science is not enough to build successful companies. As BioInnovation Institute looks beyond Denmark, CEO Jens Nielsen sees access to the right capital as...

Another round of job cuts at BMS headquarters

Bristol Myers Squibb is issuing a new round of layoffs, bringing the total number of jobs cut in its home state of New Jersey to more than 700 so far this year.

Novartis makes a move in red‑hot radiopharma space

Novartis is expanding its radiopharmaceutical pipeline through a licensing agreement with Chinese BoomRay Therapeutics worth up to 900 million dollars.

Sweden takes half of Nordic spots among world’s top healthtech companies

Ten Nordic companies have made it onto TIME’s list of the World’s Top HealthTech Companies 2026, and half of them are Swedish. Denmark accounts for three, while...

AstraZeneca receives EU approval for asthma treatment

AstraZeneca has received approval of its asthma treatment Trixeo Aerosphere in the EU.

Private clinic delivers Sweden’s first Leqembi treatment

The Alzheimer drug Leqembi is now available at a private clinic in Stockholm – for those prepared to pay hundreds of thousands of Swedish kronor. On Tuesday, th...

Pharmaceutical giants warn: Europe is losing investment

The chairs of AstraZeneca, Boehringer Ingelheim, Chiesi Group, Ipsen, GSK, Novo, Novartis, Roche and Sanofi warn in an open letter that Europe is rapidly losing...

Health economist after TLV’s assessment: Kisunla still has a chance

Despite several uncertainties, TLV’s assessment of the Alzheimer drug Kisunla offers some hope that the treatment may eventually reach Swedish healthcare. That ...

Disruptive sells former Guard platform – deal ‘not financially material’

What was formerly Guard Therapeutics became Disruptive Pharma following a reverse acquisition. Now, one of the remaining parts of the former Guard business is b...

TLV on Kisunla: High cost, high uncertainty

High treatment costs and considerable uncertainty regarding the durability of the treatment effect. That is TLV’s overall verdict on Eli Lilly’s Alzheimer therapy Kisunla.

Organoid screening workflow with ZEISS Lightfield 4D

White paper from ZEISS.

Intuitive's da Vinci 5 receives CE marking for cardiac surgery

The medical technology company Intuitive's da Vinci 5 surgical system has received CE marking for cardiac surgery in adults in Europe.

Changing jobs in the Nordics? Avoid this common mistake

It is easy to assume that working in Copenhagen, Stockholm, Oslo or Helsinki will not be all that different from working in a neighbouring Nordic country. Accor...

Petter Hartman: “Who dares to be the first customer for innovation?”

Sweden invests heavily in research and innovation, but new solutions often hit a wall when it comes to reaching the healthcare system. Unless the public sector ...

Trump calls for major change to childhood vaccines

US President Donald Trump wants some childhood vaccines to be split into five separate doses. He claims the change could reduce autism rates, despite extensive ...

Billion‑dollar merger forms a radiopharmaceutical heavyweight

Australian Telix Pharmaceuticals is acquiring Germany’s ITM in a deal worth up to USD 2.35 billion.